US FDA Issues Final Guidance On Cybersecurity In Medical Devices

Maryland: The FDA has issued the final guidance Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions. The guidance replaces Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, issued on October 2, 2014.

This document provides recommendations on medical device cybersecurity considerations, device design and labeling, and what information to include in premarket submissions. “These recommendations are intended to promote consistency, facilitate efficient premarket review and help ensure that marketed medical devices are sufficiently resilient to cybersecurity threats,” the FDA states.

The guidance emphasizes that cybersecurity is part of device safety and the quality system requirements found in 21 CFR Part 820, which may be relevant at the premarket stage, postmarket stage or both. It provides recommendations on:

 

  • How connected devices should be tested and validated against breaches that affect multiple connected devices.
  • Provides labeling recommendations for devices with cybersecurity risks.
  • Recommends that companies develop cybersecurity management plans that communicate how they will identify and communicate postmarket vulnerabilities in accordance with 21 CFR 820.100.
  • Recommends that manufacturers provide an updateability and patchability view that describes the end-to-end process that permits software updates and patches to be provided/deployed once the device is in the field.

The guidance recommends that manufacturers use device design processes such as those described in the QS regulation to support secure product development and maintenance. But, to preserve flexibility, they may use other existing frameworks that satisfy the QS regulation and align with FDA’s recommendations for using a Security Product Development Framework (SPDF). Possible frameworks to consider include, but are not limited to, the medical device-specific framework that can be found in the Medical Device and Health IT Joint Security Plan (JSP) 30 and IEC 81001-5-1 or in ANSI/ISA 62443-4-1 Security for industrial automation and control systems Part 4- 1: Product security development life-cycle requirements.

Related Posts

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Pilibhit: A joint inquiry by the chief medical officer and city magistrate has found alleged statutory violations at several private diagnostic centres and nursing homes in Pilibhit district. A report…

Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

According to the ministry, the scheme has facilitated the establishment of domestic manufacturing capabilities for a range of high-end medical devices that were earlier predominantly imported. New Delhi: The Product…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

Arogya Manthan 2026 to launch new digital health and health assurance initiatives

Arogya Manthan 2026 to launch new digital health and health assurance initiatives

Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream

Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream